You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Suppliers and packagers for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


SODIUM CHLORIDE 5% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-5802-00 12 CONTAINER in 1 CASE (0264-5802-00) / 1000 mL in 1 CONTAINER 1998-03-09
B Braun SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-5802-10 24 CONTAINER in 1 CASE (0264-5802-10) / 500 mL in 1 CONTAINER 1998-03-09
B Braun SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-5804-00 12 CONTAINER in 1 CASE (0264-5804-00) / 1000 mL in 1 CONTAINER 1988-03-09
B Braun SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-7800-09 12 CONTAINER in 1 CASE (0264-7800-09) / 1000 mL in 1 CONTAINER 2013-12-31
B Braun SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-7800-00 12 CONTAINER in 1 CASE (0264-7800-00) / 1000 mL in 1 CONTAINER 2013-12-31
B Braun SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635 NDA B. Braun Medical Inc. 0264-7800-10 24 CONTAINER in 1 CASE (0264-7800-10) / 500 mL in 1 CONTAINER 2013-12-31
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Sodium Chloride 5% in Plastic Container

Last updated: August 14, 2025

Introduction

The pharmaceutical industry relies heavily on a robust supply chain for vital compounds such as sodium chloride 5% in plastic containers. This solution, widely used as an intravenous (IV) irrigant, diluent, and in various reconstitution applications, demands high-quality suppliers adhering to strict regulatory standards. Identifying reputable suppliers ensures product safety, efficacy, and regulatory compliance, critical for healthcare providers and pharmaceutical manufacturers. This report provides a comprehensive overview of key suppliers, their global footprint, quality standards, and industry positioning.


Overview of Sodium Chloride 5% in Plastic Containers

Sodium chloride 5% (normal saline) is a sterile isotonic solution used extensively in clinical settings. The solution is typically supplied in sterile, single-use plastic containers such as bottles or bags. The primary features include:

  • Concentration: 5% w/v sodium chloride
  • Container Types: Polypropylene or polyethylene plastic bottles or bags
  • Use Cases: IV infusion, wound irrigation, reconstitution of medications, and dialysis

Given its widespread application, global supply chain reliability and compliance with good manufacturing practices (GMP) are crucial.


Key Suppliers in the Global Market

1. Baxter International Inc.

Overview: Baxter is a leading global producer of sterile IV solutions, including sodium chloride 5%. The company has a comprehensive manufacturing footprint across North America, Europe, and Asia-Pacific.

Product Features:

  • GMP-compliant manufacturing facilities
  • Wide distribution network
  • Transparent quality management system

Regulatory Compliance: Fully compliant with U.S. FDA, EMA standards, and WHO guidelines.

Market Position: Baxter supplies sodium chloride 5% in plastic containers to healthcare institutions worldwide, maintaining a reputation for reliability and product consistency.


2. B. Braun Melsungen AG

Overview: Headquartered in Germany, B. Braun is renowned for its sterile infusion solutions, including sodium chloride 5%. The company's extensive distribution channels support global reach.

Product Features:

  • Use of high-quality plastics and sterile manufacturing
  • Compatibility with existing IV setups
  • Focus on patient safety and product stability

Regulatory Compliance: Certified under GMP, ISO 13485, and other international standards.

Market Position: As a key supplier in Europe and emerging markets, B. Braun emphasizes innovation and safety in its sterile solutions.


3. Pacira BioSciences, Inc./Carey + Co.

Overview: Pacira, known mainly for its proprietary formulations, supplies sodium chloride solutions through strategic partnerships, emphasizing high purity and sterility.

Product Features:

  • Ready-to-use sterile plastic containers
  • Compatibility with various infusion devices
  • Controlled manufacturing environment

Regulatory Status: Approves under FDA and international standards, demonstrating compliance for global markets.


4. Hospira (Pfizer Inc.)

Overview: Acquired by Pfizer, Hospira is a significant supplier of sterile injectable solutions, including sodium chloride 5%. It operates manufacturing facilities across North America, Europe, and Asia.

Product Features:

  • Single-use plastic containers, including bottles and bags
  • Proven sterile processing capabilities
  • Extensive quality assurance protocols

Regulatory Compliance: GMP-compliant, with US FDA approval and CE marking for European markets.

Market Position: Trusted provider of critical infusion solutions for hospitals and clinics globally.


5. Local and Regional Suppliers

Many regional pharmaceutical manufacturers produce sodium chloride 5% in plastic containers to serve specific markets, especially in Asia, Africa, and Latin America.

  • Indoco Remedies Ltd. (India): A significant regional supplier approved under Indian GMP standards, with export licenses for several jurisdictions.
  • Sina Laboratories (China): Provides competitively priced sterile infusion solutions, adhering to domestic and international standards.
  • Crucell (South Korea): Focuses on sterile supply solutions for the Asian market.

Importance of Local Suppliers: They often offer cost-effective options and rapid delivery, but regulatory compliance and quality assurance remain critical factors.


Regulatory and Quality Considerations

Suppliers must demonstrate compliance with key standards such as:

  • GMP (Good Manufacturing Practice): For manufacturing safety and product quality.
  • ISO 13485: For medical device and related product manufacturing.
  • USP and EP Standards: Ensure chemical and microbiological quality.
  • FDA (U.S. Food and Drug Administration) approval: For products marketed in or exported to the U.S.

Furthermore, traceability, batch testing, endotoxin levels, and sterility assurance are essential factors in supplier selection.


Supply Chain and Logistics Considerations

  • Manufacturing Capacity and Lead Time: Ensure supplier can meet demand fluctuations.
  • Distribution Network: Establish reliable logistics to prevent stockouts.
  • Storage Conditions: Verify container stability under storage conditions.
  • Regulatory Documentation: Access to batch certificates, sterilization records, and compliance certificates.

Emerging Trends and Market Dynamics

  • Supply Chain Resilience: Recent disruptions highlight the importance of diversified sourcing.
  • Quality Enhancements: Suppliers investing in advanced sterilization and packaging technologies.
  • Regulatory Harmonization: Procurement increasingly aligned with international standards to facilitate global distribution.

Conclusion

The global supply for sodium chloride 5% in plastic containers is dominated by established pharmaceutical giants such as Baxter, B. Braun, Hospira, and regional manufacturers that adhere to strict quality and regulatory standards. Ensuring supply chain resilience, compliance, and product quality remains paramount for healthcare providers and manufacturers.


Key Takeaways

  • Leading global suppliers like Baxter, B. Braun, and Hospira offer high-quality sodium chloride 5% solutions in plastic containers, with extensive certifications and compliance.
  • Regional manufacturers fill critical gaps in emerging markets, often at a lower cost but require rigorous compliance verification.
  • Regulatory adherence, manufacturing capabilities, and supply chain logistics are essential considerations in supplier selection.
  • Diversification in sourcing mitigates risks associated with supply disruptions.
  • Advancements in production technology and quality assurance are shaping the future landscape of sterile infusion solutions.

FAQs

1. What certifications should I verify when selecting a sodium chloride 5% supplier?
Suppliers must demonstrate compliance with GMP, ISO 13485, USP, and EP standards. FDA approval or CE marking further validates regulatory compliance for specific markets.

2. Are regional suppliers suitable for global supply chains?
Yes, provided they meet international standards and can reliably supply consistent, sterile products. Due diligence and audits are recommended to verify quality systems.

3. How do manufacturing capacity and lead times impact procurement?
Limited capacity or long lead times can cause shortages. Engaging with suppliers with adequate capacity and robust logistics reduces supply risks.

4. What are the key quality parameters for sodium chloride 5% solutions?
Sterility, endotoxin levels, pH, osmolarity, and chemical purity are critical quality parameters regulated by pharmacopoeias.

5. How has recent global disruption affected the supply of sterile infusion solutions?
Supply chains faced challenges like manufacturing shutdowns and transportation delays. Diversifying suppliers and maintaining safety stock helps mitigate such risks.


Sources

  1. Baxter International Inc. Product Catalog. [Baxter Official Website].
  2. B. Braun Global Product Portfolio. [B. Braun Official Website].
  3. FDA Labeling and Approval Data for Sodium Chloride Solutions.
  4. WHO Guidelines on Good Manufacturing Practices for Sterile Products.
  5. Market Analysis Reports on IV Solutions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.